Advanced search
Publication Cover
Cancer Management and Research Volume 6, 2014 - Issue
Submit an article Journal homepage
60
Views
1
CrossRef citations to date
0
Altmetric
Rapid Communication

High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy

Vikram Gota1 Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Mumbai, India
,
Krunal Kavathiya1 Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Mumbai, India
,
Kartik Doshi1 Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Mumbai, India
,
Murari Gurjar1 Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Mumbai, India
,
Solai E Damodaran1 Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Mumbai, India
,
Vanita Noronha2 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
,
Amit Joshi2 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
&
Kumar Prabhash2 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, IndiaCorrespondence[email protected]
 show all
Pages 261-265 | Published online: 04 Jun 2014

References

  • D’AddarioGPintilieMLeighlNBFeldRCernyTShepherdFAPlatinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literatureJ Clin Oncol2005232926293615728229
  • LeeHYAhnMJParkYHAdenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: a prospective, multicenter trialLung Cancer20096633834319299031
  • ZukinMBarriosCHPereiraJRRandomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2J Clin Oncol2013312849285323775961
  • LiMZhangQFuPPemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trialsPLoS One2012717
  • BerghmansTHyponatremia related to medical anticancer treatmentSupport Care Cancer199643413508883227
  • eHealthMePemetrexed outcomes reported from 2555 patients Available from: http://www.ehealthme.com/pemetrexedAccessed January 5, 2014
  • CheeCEJettJRBernathAMJrPhase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423Cancer20101162382238920209614
  • SocinskiMASmitEFLoriganPPhase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancerJ Clin Oncol2009274787479219720897
  • FujiokaSNakamuraHMiwaKSyndrome of inappropriate secretion of antidiuretic hormone (SIADH) following carboplatin-paclitaxel administration in a patient with lung cancerPharmazie20116672973022026133
  • LiamisGMilionisHElisafMA review of drug-induced hyponatremiaAm J Kidney Dis20085214415318468754
  • Clinical Pharmacology ReviewAlimta™ (pemetrexed) Available from: http://www.fda.gov/downloads/Drugs/.../UCM252981.pdfAccessed December 3, 2013
  • van den BogaertDPPouwEMvan WijheGPemetrexed maintenance therapy in patients with malignant pleural mesotheliomaJ Thorac Oncol20061253017409823
  • ErdmanARMangraviteLMUrbanTJThe human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomicsAm J Physiol Renal Physiol200629015

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.